These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease. Soldan A; Pettigrew C; Zhu Y; Wang MC; Moghekar A; Gottesman RF; Singh B; Martinez O; Fletcher E; DeCarli C; Albert M; Neurology; 2020 Mar; 94(9):e950-e960. PubMed ID: 31888969 [TBL] [Abstract][Full Text] [Related]
6. MRI and CSF studies in the early diagnosis of Alzheimer's disease. de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364 [TBL] [Abstract][Full Text] [Related]
7. Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment. Strikwerda-Brown C; Hobbs DA; Gonneaud J; St-Onge F; Binette AP; Ozlen H; Provost K; Soucy JP; Buckley RF; Benzinger TLS; Morris JC; Villemagne VL; Doré V; Sperling RA; Johnson KA; Rowe CC; Gordon BA; Poirier J; Breitner JCS; Villeneuve S; JAMA Neurol; 2022 Oct; 79(10):975-985. PubMed ID: 35907254 [TBL] [Abstract][Full Text] [Related]
8. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia. Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology. Gordon BA; Blazey T; Su Y; Fagan AM; Holtzman DM; Morris JC; Benzinger TL JAMA Neurol; 2016 Oct; 73(10):1192-1200. PubMed ID: 27548756 [TBL] [Abstract][Full Text] [Related]
10. Optimizing detection of Alzheimer's disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO. Ismail Z; Leon R; Creese B; Ballard C; Robert P; Smith EE Mol Neurodegener; 2023 Jul; 18(1):50. PubMed ID: 37516848 [TBL] [Abstract][Full Text] [Related]
11. The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study. Ismail R; Parbo P; Madsen LS; Hansen AK; Hansen KV; Schaldemose JL; Kjeldsen PL; Stokholm MG; Gottrup H; Eskildsen SF; Brooks DJ J Neuroinflammation; 2020 May; 17(1):151. PubMed ID: 32375809 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging. Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956 [TBL] [Abstract][Full Text] [Related]
13. The structural MRI markers and cognitive decline in prodromal Alzheimer's disease: a 2-year longitudinal study. Wei H; Kong M; Zhang C; Guan L; Ba M; Quant Imaging Med Surg; 2018 Nov; 8(10):1004-1019. PubMed ID: 30598878 [TBL] [Abstract][Full Text] [Related]
14. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment. Guzman VA; Carmichael OT; Schwarz C; Tosto G; Zimmerman ME; Brickman AM; Alzheimers Dement; 2013 Oct; 9(5 Suppl):S124-31. PubMed ID: 23375566 [TBL] [Abstract][Full Text] [Related]
15. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601 [TBL] [Abstract][Full Text] [Related]
16. Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau. Dickerson BC; Wolk DA; Front Aging Neurosci; 2013; 5():55. PubMed ID: 24130528 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of tau deposition using Bullich S; Mueller A; De Santi S; Koglin N; Krause S; Kaplow J; Kanekiyo M; Roé-Vellvé N; Perrotin A; Jovalekic A; Scott D; Gee M; Stephens A; Irizarry M Alzheimers Res Ther; 2022 Jul; 14(1):105. PubMed ID: 35897078 [TBL] [Abstract][Full Text] [Related]
18. Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers. Marizzoni M; Ferrari C; Jovicich J; Albani D; Babiloni C; Cavaliere L; Didic M; Forloni G; Galluzzi S; Hoffmann KT; Molinuevo JL; Nobili F; Parnetti L; Payoux P; Ribaldi F; Rossini PM; Schönknecht P; Salvatore M; Soricelli A; Hensch T; Tsolaki M; Visser PJ; Wiltfang J; Richardson JC; Bordet R; Blin O; Frisoni GB; J Alzheimers Dis; 2019; 69(1):3-14. PubMed ID: 29914031 [TBL] [Abstract][Full Text] [Related]
19. Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment. Giacomucci G; Mazzeo S; Bagnoli S; Ingannato A; Leccese D; Berti V; Padiglioni S; Galdo G; Ferrari C; Sorbi S; Bessi V; Nacmias B J Neurol; 2022 Aug; 269(8):4270-4280. PubMed ID: 35288777 [TBL] [Abstract][Full Text] [Related]
20. Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease. Pettigrew C; Soldan A; Sloane K; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M; Neuroimage Clin; 2017; 16():439-446. PubMed ID: 28879085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]